Morristown, NJ—OmniActive Health Technologies has been granted a patent for its OmniBead technology platform by the European Patent office (number EP3110262B1), according to a press release.
OmniBead is beadlet technology that retains the nutritional and biological benefits of natural compounds that would otherwise have limited use in finished formulations due to physical or organoleptic characteristics. The press release says that OmniBead allows for greater formula flexibility at efficacious doses.
“This patent showcases all the elements which make Capsimax and our OmniBead technology true game-changers and differentiators in the weight wellness and sports nutrition categories,” Arti Shah, VP of global marketing at OmniActive, said in the release. “We invite customers to discuss the significant relevance and opportunities that this provides to the European market at OmniActive booth H41 during Vitafoods this year.”